MX24039A - Composiciones farmaceuticas que contienen una calcitonina como principio activo. - Google Patents
Composiciones farmaceuticas que contienen una calcitonina como principio activo.Info
- Publication number
- MX24039A MX24039A MX2403990A MX2403990A MX24039A MX 24039 A MX24039 A MX 24039A MX 2403990 A MX2403990 A MX 2403990A MX 2403990 A MX2403990 A MX 2403990A MX 24039 A MX24039 A MX 24039A
- Authority
- MX
- Mexico
- Prior art keywords
- calcitonin
- pharmaceutical compositions
- active substance
- compositions containing
- substance
- Prior art date
Links
- 102000055006 Calcitonin Human genes 0.000 title 1
- 108060001064 Calcitonin Proteins 0.000 title 1
- 239000013543 active substance Substances 0.000 title 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
- 229960004015 calcitonin Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT01911290A IT1238072B (it) | 1990-01-19 | 1990-01-19 | Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX24039A true MX24039A (es) | 1994-02-28 |
Family
ID=11154741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2403990A MX24039A (es) | 1990-01-19 | 1990-12-28 | Composiciones farmaceuticas que contienen una calcitonina como principio activo. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5441933A (es) |
| EP (1) | EP0438147A3 (es) |
| JP (1) | JPH04210924A (es) |
| KR (1) | KR910014128A (es) |
| CA (1) | CA2034519A1 (es) |
| IT (1) | IT1238072B (es) |
| MX (1) | MX24039A (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9120672D0 (en) * | 1991-09-28 | 1991-11-06 | Ciba Geigy Ag | Pharmaceutical compositions |
| EP0839526A3 (en) * | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
| EP2263660B1 (en) * | 1998-05-18 | 2017-09-27 | Takeda Pharmaceutical Company Limited | Orally disintegrable tablets |
| DE69942777D1 (de) | 1998-07-28 | 2010-10-28 | Takeda Pharmaceutical | Leicht zerfallende feste Zubereitung |
| AU776299B2 (en) * | 1998-12-01 | 2004-09-02 | Dr Reddy's Laboratories, Inc. | New pharmaceutical composition and the process for its preparation |
| US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
| US7049283B2 (en) | 2000-12-06 | 2006-05-23 | Novartis Ag | Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| ES2199061B1 (es) * | 2002-06-10 | 2005-02-16 | Laboratorios Vita, S.A. | Comprimidos bucodispersables y procedimiento para su obtencion. |
| US20040265372A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| RS20050835A (sr) * | 2004-01-06 | 2007-08-03 | Panacea Biotec Ltd., | Sastavi bukalnih doznih oblika za produženo otpuštanje leka i postupak za njihovo dobijanje |
| JP2008509933A (ja) * | 2004-08-13 | 2008-04-03 | エミスフェアー・テクノロジーズ・インク | 送達剤のマイクロ粒子またはナノ粒子を含む医薬製剤 |
| US8197858B2 (en) * | 2009-02-06 | 2012-06-12 | Mark John Zamoyski | Bone microenvironment modulated seizure treatments |
| US9486947B2 (en) * | 2013-09-30 | 2016-11-08 | Gregory D. Graves | Phosphorus treatment agent methods of manufacture and use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4151276A (en) * | 1975-05-12 | 1979-04-24 | Armour Pharmaceutical Company | Method of suppressing gastric acid secretion by the oral administration of calcitonin |
| US4663309A (en) * | 1983-06-29 | 1987-05-05 | University Patents, Inc. | Novel peptide hormones with calcitonin-like activity |
| US4530838A (en) * | 1983-07-08 | 1985-07-23 | The Salk Institute For Biological Studies | Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals |
| JPS61126034A (ja) * | 1984-11-26 | 1986-06-13 | Yamanouchi Pharmaceut Co Ltd | アルド−スを含有するカルシトニン経鼻剤 |
| US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
| JPS6210020A (ja) * | 1985-07-08 | 1987-01-19 | Kanebo Ltd | カルシトニン含有組成物 |
| IT1223132B (it) * | 1987-11-13 | 1990-09-12 | Isf Spa | Composizione farmaceutica per somministrazione nasale |
| ES2061688T3 (es) * | 1987-11-13 | 1994-12-16 | Smithkline Beecham Farma | Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion. |
-
1990
- 1990-01-19 IT IT01911290A patent/IT1238072B/it active IP Right Grant
- 1990-12-28 MX MX2403990A patent/MX24039A/es unknown
-
1991
- 1991-01-14 US US07/640,811 patent/US5441933A/en not_active Expired - Fee Related
- 1991-01-17 EP EP19910100509 patent/EP0438147A3/en not_active Withdrawn
- 1991-01-17 KR KR1019910000675A patent/KR910014128A/ko not_active Withdrawn
- 1991-01-18 JP JP3016832A patent/JPH04210924A/ja active Pending
- 1991-01-18 CA CA002034519A patent/CA2034519A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04210924A (ja) | 1992-08-03 |
| IT9019112A0 (it) | 1990-01-19 |
| CA2034519A1 (en) | 1991-07-20 |
| IT9019112A1 (it) | 1991-07-19 |
| IT1238072B (it) | 1993-07-03 |
| US5441933A (en) | 1995-08-15 |
| KR910014128A (ko) | 1991-08-31 |
| EP0438147A2 (en) | 1991-07-24 |
| EP0438147A3 (en) | 1991-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES513183A0 (es) | "un procedimiento para preparar una composicion herbicida que contiene como ingrediente activo una 3-isoxazolidinona". | |
| ITRM920361A1 (it) | Composizioni farmaceutiche contenenti un composto allilamminico quale principio attivo. | |
| ES531978A0 (es) | Un procedimiento para preparar composiciones farmaceuticas de disolucion rapida que contienen como ingrediente activo triamteremo o metolazona. | |
| AR240225A1 (es) | Composicion insecticida que comprende mas de un compuesto activo. | |
| DE69101931D1 (de) | Pharmazeutische Zusammensetzung. | |
| DE69001730D1 (de) | Pastenfoermige, waesserige pharmazeutische zusammensetzungen. | |
| DE68911473D1 (de) | Arzneimittelformulierungen. | |
| DE3863963D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE3586545D1 (de) | Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen. | |
| ES2129806T3 (es) | Composiciones liquidas orales que contienen resinato de paroxetina. | |
| DE69115263D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE3784594D1 (de) | Mikrokapseln enthaltende pharmazeutische zusammensetzungen. | |
| DE3868986D1 (de) | Pharmazeutische zusammensetzungen. | |
| DE69014498D1 (de) | Hyposensibilisierende wirksame Substanz. | |
| MX24039A (es) | Composiciones farmaceuticas que contienen una calcitonina como principio activo. | |
| FI932553A7 (fi) | Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi | |
| DE69133371D1 (de) | Pharmazeutische wirksame Benzochinazolin Verbindungen | |
| FI831952A7 (fi) | Hydrolyysiherkkää tehoainetta sisältävät, varastoinnin kestävät tabletit. | |
| IT8820386A0 (it) | Composizioni farmaceutiche orosolubili contenti acetilcisteina. | |
| NL194300B (nl) | Farmaceutisch preparaat, dat een polyprenol als werkzaam bestanddeel bevat, alsmede voor toepassing daarin geschikte polyprenolen. | |
| BE896357A (fr) | Medicament a action salidiuretique, contenant des dihydropyridines, | |
| IT7922743A0 (it) | Componente di dosaggio farmaceutico a emissione controllata. | |
| FI910254L (fi) | Oralt aktiva renininhibitorer. | |
| IT8620865A0 (it) | Composizioni farmaceutiche contenenti una calcitonina. | |
| DE3873011D1 (de) | Pharmazeutische zusammensetzung, enthaltend piperidinalkanolderivate. |